News and Announcements
Briars Funds Management Pty Limited and Briars Private Mortgage Fund raises initial $5m Warehouse Funding tranche to continue its rollout of First & Second Mortgages to Consumers and Businesses
- Published July 14, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Briars Funds Management Pty Limited announces agreement on $20m Wholesale Funding line, with the initial $5m tranche to be released in August 2020.
This will enable Briars to grow their signature product nationally & help established homeowners release equity in their homes.
About Briars Private Mortgage Fund
The Briars Private Mortgage Fund was established to provide investors with above average, stable returns by investing in a pool of 1st and 2nd mortgages secured against established metropolitan residential real estate and personal guarantees.
Benefits of the Fund:
- 8.5% return pa paid monthly net of all fees;
- An income-focused actively managed Mortgage Fund
- No construction funding
- Capital City focus
- Available to Wholesale Investors
As at the 30th June 2020, the Fund’s weighted average LVR was 73.94%.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
